Who does this study affect: People with untreated, advanced non-small cell lung cancer (NSCLC). What did this study find: Results from the phase III CHOICE-01 clinical trial in China show that adding the immunotherapy drug toripalimab (TuoYi) to chemotherapy in people with untreated, advanced NSCLC slowed cancer growth and helped them live longer, particularly if their tumors had certain biomarkers, which are mutations, genes, or patterns found in a tumor’s […]

My normal morning suddenly became life-changing for me. I found a lump in my left breast and noticed that I also had a nipple retraction. I called my sister, Sharon, and told her that I believed I may have breast cancer. Later at work, I used my lunch break to go to see my doctor, who, confirmed my suspicion. I’m a specialist with CDC’s National Center for Health Statistics in […]

Who does this study affect: People with untreated advanced melanoma What did this study find: What did this study find: A new report from the global phase II/III RELATIVITY-047 clinical trialshows that a combination of the immunotherapy drugs relatlimab and nivolumab (Opdivo) remains effective in slowing the growth of untreated advanced melanoma. The combination treatment may also shrink the melanoma and help people with this disease live longer compared with […]

It’s tempting to want to avoid talking about addressing problems. Yet not talking about a problem will not make it go away. In general, it’s much better to actively address the problem. Here’s the difference: Active Ways to Cope Take action to get rid of the problem Plan how to deal with the problem Look for advice and information to deal with the problem Look for sympathy and emotional support […]